{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T17:31:46Z","timestamp":1747157506108,"version":"3.40.5"},"reference-count":11,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["CHEST"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.chest.2022.03.016","type":"journal-article","created":{"date-parts":[[2022,8,5]],"date-time":"2022-08-05T09:06:05Z","timestamp":1659690365000},"page":"279-280","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Loss of Heterozygosity for Tuberous Sclerosis Complex and Mammalian Target of Rapamycin Signaling"],"prefix":"10.1016","volume":"162","author":[{"given":"Marissa","family":"O\u2019Callaghan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2896-5210","authenticated-orcid":false,"given":"Cormac","family":"McCarthy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.chest.2022.03.016_bib1","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/S2213-2600(21)00228-9","article-title":"Lymphangioleiomyomatosis: pathogenesis, clinical features, diagnosis, and management","volume":"9","author":"McCarthy","year":"2021","journal-title":"Lancet Respir Med"},{"issue":"161","key":"10.1016\/j.chest.2022.03.016_bib2","doi-asserted-by":"crossref","first-page":"200348","DOI":"10.1183\/16000617.0348-2020","article-title":"Tuberous sclerosis complex for the pulmonologist","volume":"30","author":"Rebaine","year":"2021","journal-title":"Eur Respir Rev"},{"issue":"6","key":"10.1016\/j.chest.2022.03.016_bib3","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1159\/000485106","article-title":"Cystic lung disease in genetic syndromes with deficient tumor suppressor gene function","volume":"94","author":"Daccord","year":"2017","journal-title":"Respiration"},{"issue":"17","key":"10.1016\/j.chest.2022.03.016_bib4","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1056\/NEJMoa1100391","article-title":"Efficacy and safety of sirolimus in lymphangioleiomyomatosis","volume":"364","author":"McCormack","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.chest.2022.03.016_bib5","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.chest.2022.02.032","article-title":"Pulmonary Langerhans cell histiocystosis and lymphangioleiomyomatosis have circulating cells with loss of heterozygosity of the TSC2 gene","volume":"162","author":"Elia","year":"2022","journal-title":"Chest"},{"issue":"10","key":"10.1016\/j.chest.2022.03.016_bib6","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1136\/thoraxjnl-2017-210125","article-title":"Current understanding and management of pulmonary Langerhans cell histiocytosis","volume":"72","author":"Vassallo","year":"2017","journal-title":"Thorax"},{"key":"10.1016\/j.chest.2022.03.016_bib7","doi-asserted-by":"crossref","first-page":"667311","DOI":"10.3389\/fcell.2021.667311","article-title":"Folliculin: a regulator of transcription through AMPK and mTOR signaling pathways","volume":"9","author":"Ramirez Reyes","year":"2021","journal-title":"Front Cell Dev Biol"},{"issue":"31","key":"10.1016\/j.chest.2022.03.016_bib8","doi-asserted-by":"crossref","first-page":"22220","DOI":"10.18632\/oncotarget.25164","article-title":"Sporadic renal angiomyolipoma in a patient with Birt-Hogg-Dub\u00e9: chaperones in pathogenesis","volume":"9","author":"Sager","year":"2018","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.chest.2022.03.016_bib9","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/s41580-019-0199-y","article-title":"mTOR at the nexus of nutrition, growth, ageing and disease","volume":"21","author":"Liu","year":"2020","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"7826","key":"10.1016\/j.chest.2022.03.016_bib10","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/s41586-020-2444-0","article-title":"A\u00a0substrate-specific mTORC1 pathway underlies Birt-Hogg-Dub\u00e9 syndrome","volume":"585","author":"Napolitano","year":"2020","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.chest.2022.03.016_bib11","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1164\/rccm.201706-1243OC","article-title":"Novel molecular and phenotypic insights into congenital lung malformations","volume":"197","author":"Swarr","year":"2018","journal-title":"Am J Respir Crit Care Med"}],"container-title":["CHEST"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369222004494?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369222004494?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T01:02:54Z","timestamp":1715130174000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369222004494"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":11,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S0012369222004494"],"URL":"https:\/\/doi.org\/10.1016\/j.chest.2022.03.016","relation":{},"ISSN":["0012-3692"],"issn-type":[{"type":"print","value":"0012-3692"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Loss of Heterozygosity for Tuberous Sclerosis Complex and Mammalian Target of Rapamycin Signaling","name":"articletitle","label":"Article Title"},{"value":"CHEST","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chest.2022.03.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.chest.2022.02.032","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}